PFIZER SHARE PRICE

Pfizer Ltd is in the Pharmaceuticals sector, having the Market Capitalization of worth Rs. 26,896.85 crores, it is incorporated in the year 1986. It has reported consolidated sales of Rs. 749.17 crores in June’2021. The company is listed in the Bombay Stock Exchange (BSE) with the code 500680, and also listed in the National Stock Exchange (NSE) with the code PFIZER.

Pfizer Ltd is the fourth largest multinational pharmaceuticals company in India. Pfizer ltd is a subsidiary of Pfizer Inc. It holds 40% ownership of Pfizer Ltd. Pfizer Ltd is also known for its award-winning manufacturing facility having state-of-the-art technology and the capacity to produce over one billion tablets annually. Some of the many top brands produced by Pfizer are Prevenar 13, Dolonex, Corex, Becosules, Gelusil, etc. Pfizer ltd enjoys a unique advantage as it gets access to Pfizer Inc’s global portfolio of therapies and introduces them into Indian markets. Pfizer ltd is also the first pharmaceutical company to start clinical research in the country. Although Pfizer ltd was incorporated in 1986, it had already entered the Indian markets in 1950 through Dumex ltd. The promoters of the company own 63.92% of the stake in the company, Foreign Institutional Investors (FII) own 1.95%, Domestic Institutional Investors (DII) own 14.96% of the stake, and others (such as public & retail
investors) hold the balance of 19.17%.

In June 2021, quarterly net revenue was Rs. 749.17 crores, which has increased by approximately 45.50 % from Rs. 380.28 crores for the April-June 2020 quarter. The quarterly net profit in June 2021 was Rs. 199.91 crores, which has also increased by nearly 60.63% from a net profit of Rs. 124.45 crores in June 2020. In June 2021, the reported operating profit was at Rs. 666.86 crores, which is also increased by 42.81% as compared to an operating profit of Rs. 466.96 crores for the quarter ending in June 2020. From Rs. 27.20 in June 2020, the EPS of Pfizer has risen to Rs. 43.69 per share in June 2021. PFIZER’s stock closed at Rs. 5879.35 on 18th August’2021 (NSE) and has returned 27.44% in the last six months and 29.38% in the previous year.

Pfizer share price as on 30 Apr 2025 is Rs. 4259.9. Over the past 6 months, the Pfizer share price has decreased by 18.02% and in the last one year, it has increased by 1.42%. The 52-week low for Pfizer share price was Rs. 3701 and 52-week high was Rs. 6451.15.

Pfizer Ltd is in the Pharmaceuticals sector, having the Market Capitalization of worth Rs. 26,896.85 crores, it is incorporated in the year 1986. It has reported consolidated sales of Rs. 749.17 crores in June’2021. The company is listed in the Bombay Stock Exchange (BSE) with the code 500680, and also listed in the National Stock Exchange (NSE) with the code PFIZER.

Pfizer Ltd is the fourth largest multinational pharmaceuticals company in India. Pfizer ltd is a subsidiary of Pfizer Inc. It holds 40% ownership of Pfizer Ltd. Pfizer Ltd is also known for its award-winning manufacturing facility having state-of-the-art technology and the capacity to produce over one billion tablets annually. Some of the many top brands produced by Pfizer are Prevenar 13, Dolonex, Corex, Becosules, Gelusil, etc. Pfizer ltd enjoys a unique advantage as it gets access to Pfizer Inc’s global portfolio of therapies and introduces them into Indian markets. Pfizer ltd is also the first pharmaceutical company to start clinical research in the country. Although Pfizer ltd was incorporated in 1986, it had already entered the Indian markets in 1950 through Dumex ltd. The promoters of the company own 63.92% of the stake in the company, Foreign Institutional Investors (FII) own 1.95%, Domestic Institutional Investors (DII) own 14.96% of the stake, and others (such as public & retail
investors) hold the balance of 19.17%.

In June 2021, quarterly net revenue was Rs. 749.17 crores, which has increased by approximately 45.50 % from Rs. 380.28 crores for the April-June 2020 quarter. The quarterly net profit in June 2021 was Rs. 199.91 crores, which has also increased by nearly 60.63% from a net profit of Rs. 124.45 crores in June 2020. In June 2021, the reported operating profit was at Rs. 666.86 crores, which is also increased by 42.81% as compared to an operating profit of Rs. 466.96 crores for the quarter ending in June 2020. From Rs. 27.20 in June 2020, the EPS of Pfizer has risen to Rs. 43.69 per share in June 2021. PFIZER’s stock closed at Rs. 5879.35 on 18th August’2021 (NSE) and has returned 27.44% in the last six months and 29.38% in the previous year.

Pfizer share price as on 30 Apr 2025 is Rs. 4259.9. Over the past 6 months, the Pfizer share price has decreased by 18.02% and in the last one year, it has increased by 1.42%. The 52-week low for Pfizer share price was Rs. 3701 and 52-week high was Rs. 6451.15.